| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10516795 | Public Health | 2005 | 5 Pages |
Abstract
The SIF has attracted injection drug users with a high burden of HCV infection and a substantial proportion of uninfected individuals. Although cross-sectional, this study provides some insight into historical risks for HCV infection among this population, and prospective follow-up of this cohort will be useful to determine if use of the SIF is associated with reduced risk behaviour and HCV incidence.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
E. Wood, T. Kerr, J. Stoltz, Z. Qui, R. Zhang, J.S.G. Montaner, M.W. Tyndall,